Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 June;51(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 June;51(2):96-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


eTOC

 

EDITORIAL  MOLECULAR IMAGING IN PHARMACOLOGYFREEfree


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 June;51(2):96-8

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

The uncertain path to the future of imaging biomarkers

Nunn A. D.

Ernst Felder Laboratories, Bracco Research USA Ltd Princeton, NJ, USA


FULL TEXT  


top of page

Publication History

Cite this article as

Corresponding author e-mail